TY - STD TI - Howlader N, et al. SEER cancer statistic review 1975–2014, National Cancer Institute; 2017. ID - ref1 ER - TY - JOUR AU - Gradishar, W. J. AU - Tjulandin, S. AU - Davidson, N. AU - Shaw, H. AU - Desai, N. AU - Bhar, P. PY - 2005 DA - 2005// TI - Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.04.937 DO - 10.1200/JCO.2005.04.937 ID - Gradishar2005 ER - TY - JOUR AU - Cortes, J. AU - O’Shaughnessy, J. AU - Loesch, D. AU - Blum, J. L. AU - Vahdat, L. T. AU - Petrakova, K. PY - 2011 DA - 2011// TI - Eribulin monotherapy versus treatment of physician’s choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study. EMBRACE (Eisai Metastatic Breast Cancer Study Assessing Physician’s Choice Versus E7389) investigators JO - Lancet VL - 377 UR - https://doi.org/10.1016/S0140-6736(11)60070-6 DO - 10.1016/S0140-6736(11)60070-6 ID - Cortes2011 ER - TY - JOUR AU - Cazzaniga, M. E. AU - Torri, V. AU - Riva, F. AU - Porcu, L. AU - Cicchiello, F. AU - Capici, S. PY - 2017 DA - 2017// TI - Efficacy and safety of vinorelbine–capecitabine oral metronomic combination in elderly metastatic breast cancer patients: VICTOR-1 study JO - Tumori VL - 103 ID - Cazzaniga2017 ER - TY - JOUR AU - Cazzaniga, M. E. AU - Cortesi, L. AU - Ferzi, A. AU - Scaltriti, L. AU - Cicchiello, F. AU - Ciccarese, M. PY - 2016 DA - 2016// TI - Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study JO - Breast Cancer Res Treat VL - 160 UR - https://doi.org/10.1007/s10549-016-4009-3 DO - 10.1007/s10549-016-4009-3 ID - Cazzaniga2016 ER - TY - JOUR AU - Cazzaniga, M. E. AU - Torri, V. AU - Villa, F. AU - Giuntini, N. AU - Riva, F. AU - Zeppellini, A. PY - 2014 DA - 2014// TI - Efficacy and safety of the all-oral schedule of metronomic vinorelbine and capecitabine in locally advanced or metastatic breast cancer patients: the phase I-II VICTOR-1 Study JO - Int J Breast cancer VL - 2014 UR - https://doi.org/10.1155/2014/769790 DO - 10.1155/2014/769790 ID - Cazzaniga2014 ER - TY - JOUR AU - Finek, J. AU - Holubec, L. AU - Svoboda, T. AU - Sefrhansova, L. AU - Pavlikova, I. AU - Votavova, M. PY - 2009 DA - 2009// TI - A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer JO - Anticancer Res VL - 29 ID - Finek2009 ER - TY - JOUR AU - Jones, A. AU - O’Brien, M. AU - Sommer, H. AU - Nowara, E. AU - Welt, A. AU - Pienkowski, T. PY - 2010 DA - 2010// TI - Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes JO - Cancer Chemother Pharmacol VL - 65 UR - https://doi.org/10.1007/s00280-009-1081-y DO - 10.1007/s00280-009-1081-y ID - Jones2010 ER - TY - JOUR AU - Pusztai, L. AU - Moulder, S. AU - Altan, M. AU - Kwiatkowski, D. AU - Valero, V. AU - Ueno, N. T. PY - 2014 DA - 2014// TI - Gene signature-guided dasatinib therapy in metastatic breast cancer JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-14-0800 DO - 10.1158/1078-0432.CCR-14-0800 ID - Pusztai2014 ER - TY - JOUR AU - Fornier, M. N. AU - Morris, P. G. AU - Abbruzzi, A. AU - D’Andrea, G. AU - Gilewski, T. AU - Bromberg, J. PY - 2011 DA - 2011// TI - A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer JO - Ann Oncol VL - 22 UR - https://doi.org/10.1093/annonc/mdr018 DO - 10.1093/annonc/mdr018 ID - Fornier2011 ER - TY - JOUR AU - Zhang, X. H. AU - Wang, Q. AU - Gerald, W. AU - Hudis, C. A. AU - Norton, L. AU - Smid, M. PY - 2009 DA - 2009// TI - Latent bone metastasis in breast cancer tied to Src-dependent survival signals JO - Cancer Cell VL - 16 UR - https://doi.org/10.1016/j.ccr.2009.05.017 DO - 10.1016/j.ccr.2009.05.017 ID - Zhang2009 ER - TY - JOUR AU - Araujo, J. AU - Logothetis, C. PY - 2008 DA - 2008// TI - Targeting SRC signaling in metastatic bone disease JO - Int J Cancer VL - 124 UR - https://doi.org/10.1002/ijc.23998 DO - 10.1002/ijc.23998 ID - Araujo2008 ER - TY - JOUR AU - Myoui, A. AU - Nishimura, R. AU - Williams, P. J. PY - 2003 DA - 2003// TI - C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis JO - Cancer Res VL - 63 ID - Myoui2003 ER - TY - JOUR AU - Schott, A. F. AU - Barlow, W. E. AU - Poznak, C. H. AU - Hayes, D. F. AU - Moinpour, C. M. AU - Lew, D. L. PY - 2016 DA - 2016// TI - Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622 JO - Breast Cancer Res Treat VL - 159 UR - https://doi.org/10.1007/s10549-016-3911-z DO - 10.1007/s10549-016-3911-z ID - Schott2016 ER - TY - JOUR AU - Mayer, E. L. AU - Baurain, J. F. AU - Sparano, J. AU - Strauss, L. AU - Campone, M. AU - Fumoleau, P. PY - 2011 DA - 2011// TI - A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0070 DO - 10.1158/1078-0432.CCR-11-0070 ID - Mayer2011 ER - TY - JOUR AU - Somlo, G. AU - Atzori, F. AU - Strauss, L. C. AU - Geese, W. J. AU - Specht, J. M. AU - Gradishar, W. J. PY - 2013 DA - 2013// TI - Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004 JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-0652 DO - 10.1158/1078-0432.CCR-12-0652 ID - Somlo2013 ER -